Genfit SA Company Top Insiders
| GNFTF Stock | USD 4.55 0.41 9.90% |
Genfit SA employs about 134 people. The company is managed by 10 executives with a total tenure of roughly 27 years, averaging almost 2.0 years of service per executive, having 13.4 employees per reported executive. Examination of Genfit SA's management performance can provide insight into the company performance.
| JeanFrancois Mouney Chairman Chairman of the Management Board, CEO |
Genfit |
Genfit SA Management Team Effectiveness
The company has return on total asset (ROA) of 0.1532 % which means that it generated a profit of $0.1532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6745 %, meaning that it generated $0.6745 on every $100 dollars invested by stockholders. Genfit SA's management efficiency ratios could be used to measure how well Genfit SA manages its routine affairs as well as how well it operates its assets and liabilities.Genfit SA Workforce Comparison
Genfit SA is rated # 5 in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 1,528. Genfit SA holds roughly 134 in number of employees claiming about 9% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.51 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.48 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.48. Genfit SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Genfit SA Price Series Summation is a cross summation of Genfit SA price series and its benchmark/peer.
Genfit SA Notable Stakeholders
A Genfit SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genfit SA often face trade-offs trying to please all of them. Genfit SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genfit SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| JeanFrancois Mouney | Chairman of the Management Board, CEO | Profile | |
| Dean Hum | COO, Chief Scientific Officer and Member of The Executive Board | Profile | |
| Stefanie Magner | Chief Affairs | Profile | |
| Pascal Caisey | Chief Officer | Profile | |
| Thomas Baetz | Chief Officer | Profile | |
| Pr Staels | CoFounder Board | Profile | |
| JeanChristophe Marcoux | Chief Officer | Profile | |
| Pascal Prigent | Chief Officer | Profile | |
| Laurent Lannoo | Corp Affairs | Profile | |
| Emilie Desodt | VicePres HR | Profile |
About Genfit SA Management Performance
The success or failure of an entity such as Genfit SA often depends on how effective the management is. Genfit SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genfit management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genfit management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 134 people.
Genfit SA Workforce Analysis
Traditionally, organizations such as Genfit SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genfit SA within its industry.Genfit SA Manpower Efficiency
Return on Genfit SA Manpower
| Revenue Per Employee | 597.5K | |
| Revenue Per Executive | 8M | |
| Net Income Per Employee | 501.9K | |
| Net Income Per Executive | 6.7M | |
| Working Capital Per Employee | 694K | |
| Working Capital Per Executive | 9.3M |
Complementary Tools for Genfit Pink Sheet analysis
When running Genfit SA's price analysis, check to measure Genfit SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit SA is operating at the current time. Most of Genfit SA's value examination focuses on studying past and present price action to predict the probability of Genfit SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit SA's price. Additionally, you may evaluate how the addition of Genfit SA to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |